Mylan CEO infuriates lawmakers at hearing on EpiPen costs

WASHINGTON - Mylan CEO Heather Bresch infuriated lawmakers as she tried to explain steep cost increases of her company's life-saving EpiPens.Outraged Republican and Democratic lawmakers on Wednesday grilled Bresch about the emergency allergy shot's sky-high price and the profits for a company with sales in excess of $11 billion. The list price of EpiPens has grown to $608 for a two-pack, an increase of more than 500 percent since 2007.In almost four hours of questioning, the soft-spoken CEO at t